Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $78,580 | 49 | 84.8% |
| Food and Beverage | $10,115 | 377 | 10.9% |
| Travel and Lodging | $3,636 | 23 | 3.9% |
| Education | $320.07 | 8 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $68,016 | 234 | $0 (2024) |
| Janssen Products, LP | $16,934 | 24 | $0 (2019) |
| Merck Sharp & Dohme LLC | $3,484 | 48 | $0 (2024) |
| ViiV Healthcare Company | $1,686 | 47 | $0 (2024) |
| Janssen Biotech, Inc. | $1,039 | 56 | $0 (2023) |
| AbbVie, Inc. | $461.12 | 9 | $0 (2019) |
| Napo Pharmaceuticals Inc | $289.51 | 5 | $0 (2024) |
| Theratechnologies Inc. | $270.27 | 10 | $0 (2019) |
| EMD Serono, Inc. | $147.85 | 7 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $94.86 | 5 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $11,212 | 41 | Gilead Sciences, Inc. ($10,429) |
| 2023 | $9,675 | 48 | Gilead Sciences, Inc. ($8,879) |
| 2022 | $4,217 | 30 | Gilead Sciences, Inc. ($3,932) |
| 2021 | $3,948 | 9 | Gilead Sciences, Inc. ($3,887) |
| 2020 | $2,702 | 33 | Gilead Sciences, Inc. ($2,436) |
| 2019 | $12,548 | 88 | Gilead Sciences, Inc. ($11,334) |
| 2018 | $17,668 | 83 | Gilead Sciences, Inc. ($8,729) |
| 2017 | $30,680 | 125 | Gilead Sciences Inc ($18,390) |
All Payment Transactions
457 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $25.93 | General |
| 12/05/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug), DELSTRIGO | Food and Beverage | In-kind items and services | $25.38 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/22/2024 | Napo Pharmaceuticals Inc | Mytesi (Drug) | Food and Beverage | Cash or cash equivalent | $124.98 | General |
| Category: Infectious Disease | ||||||
| 11/01/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $28.29 | General |
| 10/31/2024 | Gilead Sciences, Inc. | Biktarvy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,980.00 | General |
| Category: HIV | ||||||
| 10/30/2024 | Gilead Sciences, Inc. | Biktarvy (Drug) | Travel and Lodging | In-kind items and services | $655.71 | General |
| Category: HIV | ||||||
| 10/30/2024 | Gilead Sciences, Inc. | Biktarvy (Drug) | Food and Beverage | In-kind items and services | $121.58 | General |
| Category: HIV | ||||||
| 10/26/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $54.74 | General |
| 10/25/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug), DELSTRIGO | Food and Beverage | In-kind items and services | $31.76 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/22/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $33.01 | General |
| Category: HIV | ||||||
| 10/10/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $33.02 | General |
| 08/30/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $118.26 | General |
| Category: HIV | ||||||
| 08/10/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $33.02 | General |
| 08/02/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $23.57 | General |
| Category: HIV | ||||||
| 07/23/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: VACCINE | ||||||
| 07/18/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug), DELSTRIGO | Food and Beverage | In-kind items and services | $22.63 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/27/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $24.30 | General |
| 06/21/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $22.57 | General |
| Category: HIV | ||||||
| 05/30/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $26.51 | General |
| 05/16/2024 | Napo Pharmaceuticals Inc | Mytesi (Drug) | Food and Beverage | Cash or cash equivalent | $32.28 | General |
| Category: Infectious Disease | ||||||
| 05/13/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug), DELSTRIGO | Food and Beverage | In-kind items and services | $26.41 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/06/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $27.72 | General |
| Category: HIV | ||||||
| 04/26/2024 | ViiV Healthcare Company | — | Food and Beverage | In-kind items and services | $123.03 | General |
| 04/25/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug), DELSTRIGO | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 04/20/2024 | Gilead Sciences, Inc. | Biktarvy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,210.00 | General |
| Category: HIV | ||||||
About Dr. Ronald Jefferson, M.D
Dr. Ronald Jefferson, M.D is a General Practice healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/18/2007. The National Provider Identifier (NPI) number assigned to this provider is 1730389800.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ronald Jefferson, M.D has received a total of $92,651 in payments from pharmaceutical and medical device companies, with $11,212 received in 2024. These payments were reported across 457 transactions from 19 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($78,580).
Practice Information
- Specialty General Practice
- Location Los Angeles, CA
- Active Since 07/18/2007
- Last Updated 07/18/2007
- Taxonomy Code 208D00000X
- Entity Type Individual
- NPI Number 1730389800
Products in Payments
- Biktarvy (Drug) $30,004
- PREZCOBIX (Drug) $9,140
- Genvoya (Drug) $4,681
- Descovy (Drug) $3,274
- ISENTRESS (Drug) $3,128
- Odefsey (Drug) $1,524
- DOVATO (Drug) $635.54
- Symtuza (Drug) $465.12
- APRETUDE (Biological) $341.44
- Mavyret (Drug) $336.12
- Mytesi (Drug) $289.51
- PIFELTRO (Drug) $191.75
- CABENUVA (Biological) $185.00
- TROGARZO (Drug) $178.57
- SYMTUZA (Drug) $152.38
- Vemlidy (Drug) $125.00
- Viekira (Drug) $125.00
- RUKOBIA (Drug) $123.06
- GARDASIL (Biological) $118.29
- SEROSTIM (Biological) $104.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
General Practice Doctors in Los Angeles
Dr. Abdi Sameni, D.d.s, D.D.S
General Practice — Payments: $314,147
Dr. Kyle Stanley, Dds, DDS
General Practice — Payments: $304,330
Dr. Kent Hwang, D.d.s, D.D.S
General Practice — Payments: $236,217
Dr. Richard Kim, Md, MD
General Practice — Payments: $96,789
Dr. Michael Schneider, Dmd, DMD
General Practice — Payments: $79,891
Dr. Zhaoyang Pan, M.d, M.D
General Practice — Payments: $54,775